Manorama Industries Limited has informed the Exchange regarding "Press Release on Annual Audited financial results (both standalone and consolidated) for quarter and financial year ended March 31, 2026.".
MANORAMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Manorama Industries reported outstanding FY26 results with revenue of INR 13,577 Mn (up 76.1% YoY), EBITDA of INR 3,677 Mn (up 92.5% YoY), and PAT of INR 2,332 Mn (up 108.1% YoY). The company expanded EBITDA margins by 230 bps to 27.1% and PAT margins by 264 bps to 17.2%. For Q4FY26, revenue stood at INR 3,823 Mn (up 64.2% YoY). Capacity was boosted by 30% at Solvent Fractionation Plant 2 (from 25,000 to 32,500 TPA). The board announced a final dividend of INR 0.80 per share (40% of face value). The company flagged a net foreign exchange loss of INR 7.58 crore in Q4 due to MTM provisions on forward contracts. Net cash from operations was INR 259 Crores with a working capital cycle of ~125 days. Management plans strategic capex of ~INR 460 Crores over 2-3 years including a new manufacturing facility and a processing plant in Burkina Faso.
Strong all-round growth with margin expansion and a dividend announcement are positive for shareholders. The planned capex and capacity expansion signal confidence in sustained demand. However, the FX loss and MTM provisions introduce near-term volatility risk.